ICC Awards Mitsubishi $33M In Fight With Korean Pharma Co.
Korean pharmaceutical company Kolon Life Science Inc. must pay Mitsubishi Tanabe Pharma Corp. $33 million over a soured licensing partnership, the International Chamber of Commerce's International Court of Arbitration recently ruled....To view the full article, register now.
Already a subscriber? Click here to view full article